MELD-Na Score Explained: Liver Transplant Priority

If you’ve spent any time around a hepatology or transplant service, you’ve heard someone rattle off a MELD score like it’s a vital sign. In a sense, it is one — just for the liver instead of the heart or lungs. The Model for End-Stage Liver Disease, or MELD, turns three lab values most patients with cirrhosis already have on their chart — bilirubin, INR, and creatinine — into a single number that tracks with how sick the liver disease has made someone, and how likely they are to die in the next three months without a transplant. MELD-Na is the update almost everyone actually uses now: the same three labs, plus sodium, because it turned out low sodium was quietly predicting bad outcomes that the original three-variable formula was missing.

The “why” matters as much as the “what.” Before MELD, clinicians leaned on the Child-Pugh score, which works but rests partly on two subjective inputs — how bad is the patient’s ascites, how bad is their encephalopathy — that different clinicians can and do score differently for the same patient. MELD swapped subjective judgment for lab values, which made it reproducible enough that UNOS adopted it in 2002 to help decide who receives a liver first. MELD-Na followed in 2016, once enough data had accumulated showing that sodium added real, independent predictive value on top of the original three labs.

How the score is calculated

You don’t need to memorize logarithms to follow the shape of the formula: it’s a weighted combination of the natural logs of bilirubin, INR, and creatinine, using fixed multipliers from the original 2001 derivation study, plus a constant. A few bounds keep the math sensible: bilirubin, INR, and creatinine are each floored at 1.0, since the log of a value below 1 would subtract from the score — nonsensical for numbers that, if anything, reflect better liver function. Creatinine is capped at 4.0 mg/dL, and set to 4.0 automatically for anyone dialyzed at least twice in the past week (or 24 hours of CVVHD), since a higher reading there mostly reflects the dialysis schedule, not native kidney function. The sodium adjustment then layers on top of the finished MELD number, nudging it upward as sodium drops below normal, bounded to 125–137 mEq/L so one extreme reading can’t dominate the score. The final MELD-Na is bounded between 6 and 40.

Why sodium matters

Hyponatremia in cirrhosis usually isn’t an incidental lab abnormality — it typically signals that liver disease has progressed enough to disrupt how the kidneys handle free water, often alongside ascites and a falling effective circulating volume. Two patients can share identical bilirubin, INR, and creatinine yet have very different sodium levels, and the one with lower sodium reliably fares worse. That’s the rationale for MELD-Na: the same core formula, corrected for something the original three variables were missing. In practice, the gap between a patient’s MELD and MELD-Na is itself informative — a bigger gap means sodium is doing more of the work, and true risk is higher than the plain MELD number suggests.

MELD 3.0 and transplant allocation in 2026

Here’s the part worth knowing if you haven’t checked in on liver allocation policy recently: MELD-Na, as well established and widely used as it remains, is no longer the formula UNOS actually uses to rank patients on the U.S. liver transplant waitlist. That changed to MELD 3.0 in July 2023. MELD 3.0 keeps the same backbone — bilirubin, INR, creatinine, sodium — but adds serum albumin, an interaction term between sodium and albumin, a small constant favoring female candidates, and an interaction between sex and creatinine. The update responds to research showing the older formulas systematically underestimated disease severity in women, partly because creatinine is a weaker kidney-function marker in patients with lower muscle mass. For any actual transplant-listing decision, MELD 3.0 through the certified UNOS calculator is what matters, not MELD-Na — though MELD-Na remains highly relevant for research, general severity estimation, and non-allocation clinical conversations, which is what this calculator is built for.

Want to see the score for a specific set of labs? The free MELD-Na calculator runs both MELD and MELD-Na instantly, floors and caps every input exactly as the original algorithm specifies, and walks through a fully worked example with real numbers.

References

Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464–470. · Kamath PS, Kim WR; Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology. 2007;45(3):797–805. · Kim WR, Mannalithara A, Heimbach JK, et al. MELD 3.0: the Model for End-Stage Liver Disease Updated for the Modern Era. Gastroenterology. 2021;161(6):1887–1895.